Divi's Laboratories surged 5.86% to Rs 1,260 at 14:49 IST on BSE after net profit rose 23% to Rs 302 crore on 25% growth in total income to Rs 1008 crore in Q1 June 2016 over Q1 June 2015.
The result was announced after market hours on Friday, 12 August 2016.Meanwhile, the S&P BSE Sensex was down 74.98 points or 0.27% at 28,077.42.
On BSE, so far 86,000 shares were traded in the counter as against average daily volume of 45,131 shares in the past one quarter. The stock hit a high of Rs 1,279.90 so far during the day, which is a record high for the counter. The stock hit a low of Rs 1,200 so far during the day. The stock had hit a 52-week low of Rs 918.10 on 29 February 2016. The stock had outperformed the market over the past one month till 12 August 2016, advancing 2.44% compared with 1.24% rise in the Sensex. The scrip had also outperformed the market in past one quarter, surging 11.9% as against Sensex's 9.16% rise.
The large-cap company has equity capital of Rs 53.09 crore. Face value per share is Rs 2.
There was a forex gain of Rs 0.73 crore in Q1 June 2016 compared with a forex gain of Rs 21 crore in Q1 June 2015.
Divi's Laboratories is primarily engaged in the manufacture of active pharmaceutical ingredients (APIs) & intermediates for generics, custom synthesis of API's and advanced intermediates for discovery compounds for pharma giants, building blocks for peptides, building blocks for nucleotides, carotenoids and chiral ligands.
Powered by Capital Market - Live News